Displaying 2481 - 2500 of 4406
FTC Approves Modified Consent Order for Graco Inc.
Date
The Federal Trade Commission has approved a modified final order settling charges that equipment manufacturer Graco Inc.’s $650 million acquisition of certain finishing equipment businesses of...
Public Statement
Interview with FTC Commissioner Maureen Ohlhausen on C-SPAN’s “The Communicators”
Date
Advertising Allowances and Other Merchandising Payments and Services ("Fred Meyer Guides")
Rule Updated Date
The Fred Meyer Guides explain to manufacturers and wholesalers how they can provide advertising and promotional allowances and services to retailers without price discrimination and on “proportionally...
FTC Approves Final Amendments to Guides to Help Businesses Comply with Law Regarding Promotional Allowances and Services
Date
The Federal Trade Commission has approved final changes to its “Fred Meyer Guides,” which explain how suppliers can provide advertising allowances and other promotional payments and services to...
FTC Approves Final Order Preserving Future Competition in Generic Injectable Tuberculosis Drug Market
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn, Inc.’s acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp...
FTC Approves Four SCI Applications to Divest Funeral and Cemetery Assets in Georgia and Tennessee
Date
Following public comment periods, the Federal Trade Commission has approved four applications by Service Corporation International (SCI) to divest certain funeral and cemetery assets, as required...
Akorn, Inc., In the Matter of
Akorn, Inc. has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s proposed acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would likely be anticompetitive. According to the FTC’s complaint, only VersaPharm and two other firms currently have FDA approval to sell generic injectable rifampin and there are no viable substitutes for rifampin as a course of treatment for tuberculosis. The FTC’s proposed settlement with Akorn requires the company to divest its Abbreviated New Drug Application for generic injectable rifampin – which is currently pending before the Food and Drug Administration – to Watson Laboratories, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
141 0162
Federal Trade Commission and Department of Justice Sign Antitrust Cooperation Agreement with Colombia
Date
Federal Trade Commission Chairwoman Edith Ramirez has signed an antitrust cooperation agreement with the Colombian antitrust agency on behalf of the FTC. The agreement also was signed by Bill Baer...
Public Statement
Standard-Essential Patents and Licensing: An Antitrust Enforcement Perspective
Date
Chairwoman Edith Ramirez Media Statement on FTC Suing Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of AndroGel
Date
By
Edith Ramirez, Former Chairwoman
Matter Number
121 0028
File
Text of the Statement
(142.32 KB)
FTC Sues Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of the Blockbuster Drug AndroGel
Date
FTC alleges that AbbVie Inc. and Besins Healthcare Inc. filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of AndroGel...
Motorola Mobility LLC v. AU Optronics Corp.
Date
Citation Number
14-8003
Federal Court
U.S. Circuit Court of Appeals for the Second Circuit
Brief of the United States Department of Justice, Federal Trade Commission, Department of State, and Department of Commerce before the U.S. Court of Appeals for the Seventh Circuit addressing the...
File
Motorola Mobility LLC v. AU Optronics Corp.
(163.57 KB)
Statement of the Commission - In the Matter of Phoebe Putney Health System, Inc., Phoebe Putney Memorial Hospital, Inc., Phoebe North, Inc., HCA Inc., Palmyra Park Hospital, Inc., and Hospital Authority of Albany-Dougherty County
Date
By
Julie Brill, Former Commissioner
Matter Number
111 0067
Docket Number
9348
File
Statement of the Commission
(43.16 KB)
FTC Approves Final Order Preserving Competition in Four Generic Drug Markets
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Actavis plc’s acquisition of Forest Laboratories, Inc. would likely be anticompetitive...
FTC Approves Sales of Airport Car Rental Assets in Portland, Oregon and San Jose, California
Date
Following a public comment period, the Federal Trade Commission has approved an application submitted by Franchise Services of North America, Inc. (FSNA) to sell two former Advantage Rent A Car...
In Phoebe Putney Hospital Merger Case, FTC Rejects Proposed Consent Agreement; Parties to Return to Litigation
Date
The Federal Trade Commission rejected a proposed settlement agreement with Phoebe Putney Health System, Inc. , and returned the matter to administrative court to assess whether Phoebe’s 2011 merger...
Displaying 2481 - 2500 of 4406